Amicus Therapeutics (FOLD) Leases (2019 - 2025)
Historic Leases for Amicus Therapeutics (FOLD) over the last 7 years, with Q3 2025 value amounting to $21.5 million.
- Amicus Therapeutics' Leases fell 689.16% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 million, marking a year-over-year decrease of 689.16%. This contributed to the annual value of $22.3 million for FY2024, which is 1533.14% down from last year.
- Per Amicus Therapeutics' latest filing, its Leases stood at $21.5 million for Q3 2025, which was down 689.16% from $22.0 million recorded in Q2 2025.
- Amicus Therapeutics' 5-year Leases high stood at $30.4 million for Q2 2022, and its period low was $20.6 million during Q4 2021.
- Its 5-year average for Leases is $24.9 million, with a median of $23.0 million in 2024.
- In the last 5 years, Amicus Therapeutics' Leases crashed by 3119.29% in 2021 and then surged by 4346.64% in 2022.
- Amicus Therapeutics' Leases (Quarter) stood at $20.6 million in 2021, then soared by 43.47% to $29.5 million in 2022, then fell by 10.91% to $26.3 million in 2023, then dropped by 15.33% to $22.3 million in 2024, then fell by 3.27% to $21.5 million in 2025.
- Its Leases stands at $21.5 million for Q3 2025, versus $22.0 million for Q2 2025 and $22.1 million for Q1 2025.